Use of Complementary and Integrative Medicine Among Patients With Glioblastoma Multiforme Seen at a Tertiary Care Center

BACKGROUND: Glioblastoma multiforme (GBM) is among the most aggressive and lethal tumors, with a median survival of 12–15 months. Many patients use complementary and integrative medicine (CIM) therapies to supplement their cancer treatment. OBJECTIVE: To determine the prevalence of CIM use and ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Munoz-Casabella, Amanda, Wahner-Roedler, Dietlind L., Croghan, Ivana T., Petterson, Tanya M., Fuehrer, Debbie L., Bauer, Brent A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961379/
https://www.ncbi.nlm.nih.gov/pubmed/35360507
http://dx.doi.org/10.1177/2164957X221078543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961379/
https://www.ncbi.nlm.nih.gov/pubmed/35360507
http://dx.doi.org/10.1177/2164957X221078543

Ejemplares similares